Partner With Us

The VLST Opportunity

VLST's business model focuses on utilizing its proprietary genomic scale bioinformatics-proteomics platform to identify virulence factor cellular target interactions for the development of novel biologic therapies that have a far greater likelihood of success in clinical trials than standard discovery methods.

With a wealth of high potential interactions identified, VLST is constantly balancing the need for advancement of our internal programs with the continued development of our growing list of opportunities. Our alliance strategy is focused on program- and indication-exclusive partnerships that develop VLST product candidates for commercialization, particularly for autoimmune and inflammatory disorders. Strategic alliances can further be structured on the basis of collaboration roles, territory, and financial risk sharing.